AIMS: To determine the outcome of colorectal liver metastasis (CRLM) patients based on tumour burden, represented by tumour number and size, and tumour biology as assessed by an inflammatory response to tumour (IRT) and margin positivity. METHODS: Data were collated from CRLM patients undergoing resection from January 1993 to March 2007. Patients were divided into: low (<or=3 metastases and/or <or=3 cm); moderate (4-7 metastases and/or >3-<or=5 cm); and high (>or=8 metastases and/or >5 cm) tumour burden. RESULTS: Seven hundred and five patients underwent resection, of which 154 (21.8%), 262 (37.2%) and 289 (41.0%) patients were in the low, moderate and high tumour burden groups, respectively. The 5-year disease-free (P < 0.001) and overall (P < 0.001) survival were significantly different between the groups. IRT (P < 0.001), extent of resection (P < 0.001) and margin (P < 0.001) also differed between the groups. Sub-group analysis revealed that IRT was the only adverse predictor for disease-free and overall survival in the low group. In the moderate group, IRT predicted poorer disease-free survival on multi-variate analysis. In the high group, R1 resection and transfusion were predictors of poorer disease-free survival and age >or=65 years, R1 resection and IRT were adverse predictors of overall survival. CONCLUSION: Resection margin influenced the outcome of patients with high tumour burden, hence the importance of achieving clear margins. IRT influenced the outcome of patients with less aggressive disease.
AIMS: To determine the outcome of colorectal liver metastasis (CRLM) patients based on tumour burden, represented by tumour number and size, and tumour biology as assessed by an inflammatory response to tumour (IRT) and margin positivity. METHODS: Data were collated from CRLM patients undergoing resection from January 1993 to March 2007. Patients were divided into: low (<or=3 metastases and/or <or=3 cm); moderate (4-7 metastases and/or >3-<or=5 cm); and high (>or=8 metastases and/or >5 cm) tumour burden. RESULTS: Seven hundred and five patients underwent resection, of which 154 (21.8%), 262 (37.2%) and 289 (41.0%) patients were in the low, moderate and high tumour burden groups, respectively. The 5-year disease-free (P < 0.001) and overall (P < 0.001) survival were significantly different between the groups. IRT (P < 0.001), extent of resection (P < 0.001) and margin (P < 0.001) also differed between the groups. Sub-group analysis revealed that IRT was the only adverse predictor for disease-free and overall survival in the low group. In the moderate group, IRT predicted poorer disease-free survival on multi-variate analysis. In the high group, R1 resection and transfusion were predictors of poorer disease-free survival and age >or=65 years, R1 resection and IRT were adverse predictors of overall survival. CONCLUSION: Resection margin influenced the outcome of patients with high tumour burden, hence the importance of achieving clear margins. IRT influenced the outcome of patients with less aggressive disease.
Authors: Chandrakanth Are; Mithat Gonen; Kathleen Zazzali; Ronald P Dematteo; William R Jarnagin; Yuman Fong; Leslie H Blumgart; Michael D'Angelica Journal: Ann Surg Date: 2007-08 Impact factor: 12.969
Authors: J Y Douillard; D Cunningham; A D Roth; M Navarro; R D James; P Karasek; P Jandik; T Iveson; J Carmichael; M Alakl; G Gruia; L Awad; P Rougier Journal: Lancet Date: 2000-03-25 Impact factor: 79.321
Authors: L B Saltz; J V Cox; C Blanke; L S Rosen; L Fehrenbacher; M J Moore; J A Maroun; S P Ackland; P K Locker; N Pirotta; G L Elfring; L L Miller Journal: N Engl J Med Date: 2000-09-28 Impact factor: 91.245
Authors: S Suzuki; T Sakaguchi; Y Yokoi; K Kurachi; K Okamoto; T Okumura; Y Tsuchiya; T Nakamura; H Konno; S Baba; S Nakamura Journal: Surgery Date: 2001-04 Impact factor: 3.982
Authors: James S Tomlinson; William R Jarnagin; Ronald P DeMatteo; Yuman Fong; Peter Kornprat; Mithat Gonen; Nancy Kemeny; Murray F Brennan; Leslie H Blumgart; Michael D'Angelica Journal: J Clin Oncol Date: 2007-10-10 Impact factor: 44.544
Authors: Shaheen Zakaria; John H Donohue; Florencia G Que; Michael B Farnell; Cathy D Schleck; Duane M Ilstrup; David M Nagorney Journal: Ann Surg Date: 2007-08 Impact factor: 12.969
Authors: K J Halazun; A Aldoori; H Z Malik; A Al-Mukhtar; K R Prasad; G J Toogood; J P A Lodge Journal: Eur J Surg Oncol Date: 2007-04-19 Impact factor: 4.424
Authors: Dhanwant Gomez; Abed M Zaitoun; Antonella De Rosa; Sina Hossaini; Ian J Beckingham; Adam Brooks; Iain C Cameron Journal: HPB (Oxford) Date: 2014-03-12 Impact factor: 3.647
Authors: Pieter M H Nierop; Diederik J Höppener; Eric P van der Stok; Boris Galjart; Florian E Buisman; Vinod P Balachandran; William R Jarnagin; T Peter Kingham; Peter J Allen; Jinru Shia; Peter B Vermeulen; Bas Groot Koerkamp; Dirk J Grünhagen; Cornelis Verhoef; Michael I D'Angelica Journal: HPB (Oxford) Date: 2019-11-15 Impact factor: 3.647
Authors: Matthew G Wiggans; Golnaz Shahtahmassebi; Paul Malcolm; Frances McCormick; Somaiah Aroori; Matthew J Bowles; David A Stell Journal: HPB (Oxford) Date: 2012-12-27 Impact factor: 3.647
Authors: Pulathis N Siriwardana; Tu Vinh Luong; Jennifer Watkins; Helen Turley; Mohamed Ghazaley; Kevin Gatter; Adrian L Harris; Daniel Hochhauser; Brian R Davidson Journal: Medicine (Baltimore) Date: 2016-02 Impact factor: 1.889